HomeNewsOpinionSuspension of IBC: It’s a half-baked solution to ease financial stress

Suspension of IBC: It’s a half-baked solution to ease financial stress

Even in developed jurisdictions, none have suspended ability of debtor companies to submit themselves to the insolvency process

May 19, 2020 / 09:41 IST
Story continues below Advertisement

Hemant Kothari

Finance Minister Nirmala Sitharaman on Sunday announced several measures to provide relief to companies that face the threat of insolvency as a result of defaults owing to the COVID-19 pandemic. In line with earlier announcements, the FM said the government will bring in an ordinance to suspend the initiation of fresh insolvency cases for a year. Further, the definition of ‘default’ that forms the basis of initiation of the proceedings under the Insolvency and Bankruptcy Code 2016 (IBC) will be amended to exclude COVID-19 related debt.

Story continues below Advertisement

As for MSMEs (Micro, Small and Medium Enterprises), a special insolvency resolution framework will be notified soon. These measures are in addition to the increase in the threshold for default to trigger insolvency to Rs 1 crore from Rs 1 lakh, which was notified on March 24.

I had earlier argued here that instead of suspending IBC, it can be used as an efficient and time-bound tool to allow creditors and debtors to quickly address the problem of distress and immediately resume economic activities. However, for better or worse, given the FM’s announcement to suspend the IBC, it is now important to understand the effects of such a suspension.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show